ITT Expands Engineering and Manufacturing Site in Saudi Arabia with ~$25 Million Investment, Doubling Capacity for Middle East Customers
STAMFORD, Conn.–(BUSINESS WIRE)–Nov. 17, 2025– ITT Inc. (NYSE: ITT) today announced the completion of the second phase of a planned ~$25 million... Read more.
Enpro Inc. Completes Acquisition of AlpHa Measurement Solutions
CHARLOTTE, N.C.–(BUSINESS WIRE)–Enpro Inc. (NYSE: NPO), an industrial technology company, today announced that it has completed the previously announced... Read more.
Burgess, the Global Leader in the Superyacht Sector, Receives Strategic Investment from Ancient
LONDON & NEW YORK–(BUSINESS WIRE)–Ancient, a long-term investor in building enduring platforms across specialty finance and services, today announced... Read more.
‘Tis the Season of Savings: BJ’s Wholesale Club Black Friday Deals Begin November 17
Unbeatable value on toys, tech, home and more, plus limited-time Doorbusters MARLBOROUGH, Mass.–(BUSINESS WIRE)–BJ’s Wholesale Club (NYSE: BJ) is delivering... Read more.
Empire Petroleum Reports Third Quarter 2025 Results, Advances Development, and Positions for 2026 Growth
TULSA, Okla.–(BUSINESS WIRE)–Empire Petroleum (NYSE American: EP) (“Empire” or the “Company”), an oil and gas company with producing assets in... Read more.
Cognyte to Feature Latest Homeland Security Innovations at Milipol Paris 2025
HERZLIYA, Israel–(BUSINESS WIRE)–#Milipol2025—Cognyte Software Ltd. (NASDAQ: CGNT) (“Cognyte”), a global leader in software-driven technology... Read more.
Integrated Dermatology Strengthens Executive Team with Promotion of Nicholas Anguish to President
BOCA RATON, Fla.–(BUSINESS WIRE)–#Dermatology—Integrated Dermatology, the country’s largest independent dermatology provider, is pleased to announce... Read more.
Avicena Advances microLED and Photo Detector Arrays to Enable the World’s Lowest-Power AI Scale-up Optical Interconnects
Latest Avicena LightBundle technology delivers industry-leading Tx power of 80fJ/bit addressing next generation AI infrastructure requirements ST. LOUIS–(BUSINESS... Read more.
Hims & Hers Names Deb Autor as Chief Policy Officer to Lead Global Policy and Regulatory Strategy
SAN FRANCISCO–(BUSINESS WIRE)–Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the appointment of... Read more.
Positive Phase 3 Results Support ZIIHERA® as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA® and Chemotherapy as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma
ZIIHERA plus TEVIMBRA and chemotherapy demonstrated clinically meaningful and statistically significant improvements in PFS and OS versus trastuzumab and chemotherapy... Read more.